Omega-3 Fatty Acid Drug May Reduce Rate Of Cardiovascular Events In People With Heart Disease Or Type 2 Diabetes,

https://www.nytimes.com/2018/09/25/well/fish-oil-heart-attack-stroke-triglycerides-omega-3s.html reports in “Well” that early results of a large clinical trial suggest a drug called Vascepa, which is made up of “large doses of EPA, an omega-3 fatty acid contained in fish oil,” can sharply reduce “the rate of cardiovascular events in people with a history of heart disease or Type 2 diabetes” and high triglycerides. While previous clinical trials looking “at fish oil in heart patients had not found convincing evidence that it helps,” some experts “argued that the trials were deeply flawed, saying they relied on doses that were too small or that they failed to recruit the patients who were most likely to benefit, like those with high triglycerides.” Along with “lowering cardiovascular events, the [latest] trial found that Vascepa was safe and well tolerated